Dosimetric associations between high-dose cardiac exposure and global longitudinal strain deterioration after definitive radiotherapy for lung cancer
High-dose ventricular cardiac exposure during definitive radiotherapy for lung cancer is associated with subclinical myocardial dysfunction as measured by GLS, with a disproportionately greater impact among patients with hypertension, which supports ventricular dose optimization and hypertension-informed cardiac surveillance strategies in lung cancer radiotherapy.